Source: Healio Coverage
October 14, 2020
1 min read
Save

Top in endocrinology: Menopausal hormone therapy, irregular menstrual cycles

Source: Healio Coverage
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Brain effects of menopausal hormone therapy differ based on the route of delivery, according to a recent study. It was the top story in endocrinology last week.

Another top story was about a potential association between long or irregular menstrual cycles and an increased risk for premature mortality.

Brain scans
Source: Adobe Stock

Read these and more top stories in endocrinology below:

Brain effects of menopausal HT differ for pill, patch delivery

Early menopausal women experienced different changes in cognitive health imaging biomarkers based on route of delivery of hormone therapy vs. placebo in the Kronos Early Estrogen Prevention Study, according to a speaker at the North American Menopause Society virtual meeting. Read more.

Long, irregular menstrual cycles may predict premature mortality

Women reporting consistently long or irregular menstrual cycles are more likely to die of cancer or cardiovascular disease compared with women who report regular menses, according to data published in The BMJ. Read more.

Study confirms reduced efficacy of hormonal contraceptives with antibiotic use

Common antibiotic drugs — even those that do not induce enzymes — may reduce the effectiveness of hormonal contraceptives and lead to unintended pregnancy, according to study data published in BMJ Evidence-Based Medicine. Read more.

Smart insulin pens address challenges of multiple daily injection therapy

In this article, Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with nurse practitioner and diabetes care and education specialist Colleen Miller-Owen, MSN, APRN, CDCES, about the benefits of smart insulin pens for multiple daily injections. Read more.

Acella recalls some levothyroxine tablets due to subpotency

Acella Pharmaceuticals is voluntarily recalling one lot of 15 mg and one lot of 120 mg levothyroxine and liothyronine tablets due to subpotency, according to an FDA announcement. Read more.

click me